Andrea R Genazzani, WCO IOF-ESCEO 2022: Hormone Replacement Therapy for Bone Loss Prevention Post Menopause

Two speeches on Hormone Replacement Therapy for Bone Loss Prevention Post Menopause have been presented at WCO IOF-ESCEO 2022 by professor Genazzani

[PART 1]
  • When and in whom should HRT be considered for bone loss prevention? (1:16)
  • How can HRT be administered? (3:45)
  • For how long should HRT be administered? (5:59)
[PART 2]
  • Could you give us a brief overview of the health burden of osteoporosis in post-menopausal women? (1:15)
  • What evidence exists for the efficacy of hormone replacement therapy (HRT) for bone loss prevention in post-menopausal women? (2:44)

This site uses cookies for functional and marketing purposes. Accepting this banner you will consent the use of marketing cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close